🔎Today’s Daily Sift: Longevity Preview Longevity just crossed a threshold. Biology is shifting from observation to control. ⸻ Macro Your body is becoming a live data stream. Continuous biometrics and AI driven drug discovery are collapsing the gap between simulation and real biology. ⸻ Breakthroughs New data shows safer partial cellular reprogramming. Scientists are reducing biological age markers without triggering dangerous cell instability. At the same time, mitochondrial optimization research suggests we can mimic caloric restriction benefits without extreme dieting. ⸻ Markets Longevity startups are dropping the “wellness” label and moving toward regulated therapeutics. Pharma is paying attention. Aging is starting to look like the next major disease category. ⸻ Capital Flows Money is concentrating in three zones Epigenetic reprogramming Senolytics clearing damaged cells AI driven biomarker tracking If it cannot be measured, it is not getting funded. ⸻ Regulation Agin...